FR2858556B1 - Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation - Google Patents

Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Info

Publication number
FR2858556B1
FR2858556B1 FR0350403A FR0350403A FR2858556B1 FR 2858556 B1 FR2858556 B1 FR 2858556B1 FR 0350403 A FR0350403 A FR 0350403A FR 0350403 A FR0350403 A FR 0350403A FR 2858556 B1 FR2858556 B1 FR 2858556B1
Authority
FR
France
Prior art keywords
pelletized
dispersible
preparing
pharmaceutical composition
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0350403A
Other languages
English (en)
Other versions
FR2858556A1 (fr
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galenix Innovations Sas
PHARMINNOVATION
Original Assignee
Galenix Innovations Sas
PHARMINNOVATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0350403A priority Critical patent/FR2858556B1/fr
Application filed by Galenix Innovations Sas, PHARMINNOVATION filed Critical Galenix Innovations Sas
Priority to PCT/FR2004/050376 priority patent/WO2005013957A2/fr
Priority to JP2006522382A priority patent/JP2007501205A/ja
Priority to CA002535026A priority patent/CA2535026A1/fr
Priority to AU2004262964A priority patent/AU2004262964A1/en
Priority to EP04786374A priority patent/EP1653936A2/fr
Priority to US10/567,345 priority patent/US20070218129A1/en
Publication of FR2858556A1 publication Critical patent/FR2858556A1/fr
Application granted granted Critical
Publication of FR2858556B1 publication Critical patent/FR2858556B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
FR0350403A 2003-08-06 2003-08-06 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation Expired - Fee Related FR2858556B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0350403A FR2858556B1 (fr) 2003-08-06 2003-08-06 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
JP2006522382A JP2007501205A (ja) 2003-08-06 2004-08-05 少なくともメトホルミン活性成分を含有する非フィルムコーティーング分散性および／または口内分散性固形調合組成物、およびその製造方法
CA002535026A CA2535026A1 (fr) 2003-08-06 2004-08-05 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
AU2004262964A AU2004262964A1 (en) 2003-08-06 2004-08-05 Solid dispersible and/or orodispersible non-filmy containing at least one type of active substance pharmaceutical composition and method for the preparation thereof
PCT/FR2004/050376 WO2005013957A2 (fr) 2003-08-06 2004-08-05 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP04786374A EP1653936A2 (fr) 2003-08-06 2004-08-05 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
US10/567,345 US20070218129A1 (en) 2003-08-06 2004-08-05 Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0350403A FR2858556B1 (fr) 2003-08-06 2003-08-06 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Publications (2)

Publication Number Publication Date
FR2858556A1 FR2858556A1 (fr) 2005-02-11
FR2858556B1 true FR2858556B1 (fr) 2006-03-10

Family

ID=34073131

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0350403A Expired - Fee Related FR2858556B1 (fr) 2003-08-06 2003-08-06 Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation

Country Status (7)

Country Link
US (1) US20070218129A1 (fr)
EP (1) EP1653936A2 (fr)
JP (1) JP2007501205A (fr)
AU (1) AU2004262964A1 (fr)
CA (1) CA2535026A1 (fr)
FR (1) FR2858556B1 (fr)
WO (1) WO2005013957A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1814528A2 (fr) * 2004-10-08 2007-08-08 Rubicon Research Private Limited Procede pour fabriquer des compositions fortement compressible a delivrance controllee de metformine
SI1878426T1 (sl) * 2005-04-26 2010-09-30 Dainippon Sumitomo Pharma Co Granulatni pripravek ki vsebuje bigvanidno spojino
WO2006122021A1 (fr) * 2005-05-10 2006-11-16 Novartis Ag Procede d'extrusion permettant de fabriquer des compositions renfermant des composes therapeutiques peu compressibles
JP5165582B2 (ja) * 2005-12-16 2013-03-21 メルク・シャープ・エンド・ドーム・コーポレイション ジペプチジルペプチダーゼ−４インヒビターとメトホルミンとを組み合わせた医薬組成物
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
WO2011154975A2 (fr) * 2010-06-08 2011-12-15 Cadila Healthcare Limited Compositions pharmaceutiques de metformine
WO2013077825A1 (fr) 2011-11-23 2013-05-30 Mahmut Bilgic Procédé de fabrication d'une préparation comprenant de la metformine
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
WO2014144512A1 (fr) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Company Forme pharmaceutique à dispersion rapide contenant du lévétiracétam
JP6466399B2 (ja) 2013-03-15 2019-02-06 アプレシア・ファーマスーティカルズ・カンパニー トピラマートの急速分散性の剤形
WO2014143935A1 (fr) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Company Forme posologique d'oxcarbazépine à dispersion rapide
WO2015071859A1 (fr) * 2013-11-18 2015-05-21 Ranbaxy Laboratories Limited Composition dispersible orale d'un inhibiteur de dpp-iv
EP3248594A1 (fr) 2016-05-25 2017-11-29 ratiopharm GmbH Comprimé pour multiples applications orales
CN108272762B (zh) * 2018-03-15 2020-01-14 西南大学 香椿老叶总黄酮分散片及其制备方法
CA3183295A1 (fr) 2020-06-26 2021-12-30 Jaedeok Yoo Comprimes rapidement orodispersibles a cavite interieure

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1216486B (de) * 1964-04-23 1966-05-12 Merck Ag E Verfahren zur Herstellung von Dragees
JPS5438167B2 (fr) * 1974-04-27 1979-11-19
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
JP4278863B2 (ja) * 1997-12-08 2009-06-17 ブリストル−マイヤーズ スクイブ カンパニー メトホルミンの新規塩および方法
KR100775154B1 (ko) * 1997-12-19 2007-11-12 스미스클라인 비참 코포레이션 바이트-분산성 정제의 제조 방법
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
US6100300A (en) * 1998-04-28 2000-08-08 Bristol-Myers Squibb Company Metformin formulations and method for treating intermittent claudication employing same
JP4606582B2 (ja) * 1998-04-29 2011-01-05 大日本住友製薬株式会社 ビグアナイド系薬物の内服製剤
DK1736144T3 (en) * 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
US6274608B1 (en) * 1999-04-20 2001-08-14 Novo Nordisk A/S Compounds, their preparation and use
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP2003520226A (ja) * 2000-01-21 2003-07-02 ノバルティス アクチエンゲゼルシャフト ジペプチジルペプチダーゼ−ｉｖ阻害剤および抗糖尿病薬剤を含む組合せ物
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
IN192750B (fr) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
US7183321B2 (en) * 2001-12-17 2007-02-27 Bristol-Myers Squibb Company Antidiabetic formulation and method
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
WO2004017896A2 (fr) * 2002-08-21 2004-03-04 Merck & Co., Inc. Traitement combine faisant intervenir un double agoniste de ppar alpha/gamma et un recepteur de type i d'angiotensine ii

Also Published As

Publication number Publication date
AU2004262964A1 (en) 2005-02-17
CA2535026A1 (fr) 2005-02-17
FR2858556A1 (fr) 2005-02-11
EP1653936A2 (fr) 2006-05-10
WO2005013957A2 (fr) 2005-02-17
JP2007501205A (ja) 2007-01-25
US20070218129A1 (en) 2007-09-20
WO2005013957A3 (fr) 2005-05-26

Similar Documents

Publication Publication Date Title
FR2858556B1 (fr) Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
CA2481848A1 (fr) Particules d'ingredients actifs comprenant du clopidogrel ou un sel, leurs utilisations et procede de preparation
MY150958A (en) Compounds for the treatment of multi-drug resistant bacterial infections
WO2007070052A3 (fr) Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
DE60210552D1 (de) Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält
WO2008128775A3 (fr) Composition pharmaceutique stabilisée contenant de la prégabaline
IL159247A0 (en) Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
WO2006096444A3 (fr) Composes chimiques
MA27206A1 (fr) Azetidinones substituees par des groupements acides, procede pour leur preparation, medicaments contenant lesdits composes et utilisation de ceux-ci.
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
CA2530613A1 (fr) Peptide derive de rasgap pour tuer selectivement des cellules cancereuses
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
WO2004039326A3 (fr) Propofol associe a la cysteine
BR9810433A (pt) Composições anti-helmìnticas
FR2882522B1 (fr) Composition pharmaceutique solide comprenant de la telithromycine
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
FR2907682B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant comme principe actif au moins un peptide et utilisation de ce peptide.
DZ3103A1 (fr) Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation.
NO20041878D0 (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
RU2002121504A (ru) Лекарственные средства для лечения дегенеративного артрита
DE602006002328D1 (de) Polysubstituierte 1,1-pyridinyloxycyclopropanamine Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen
TH65470A (th) อนุพันธ์ไพโรลลิโดนที่เป็นสารยับยั้ง maob
WO2004075922A3 (fr) Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisation et lesdits agents de liaison

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20200406